AMSF AMERISAFE, Inc.
$25.30▼ -0.63%
Financials
Other
After hours
$25.30▲ +0.00%
Oct 28, 4:10 PM ET
Volume 260.4K
Avg Volume (10D) 311.2K
Key Metrics & Fundamentals
Market Cap
$468.96M
P/E Ratio
10.2
Div Yield
6.44%
52W Range
23.20 - 42.10
% vs 50 MA
1.50%
% vs 200 MA
-18.20%
RSI-14
53.0
MACD Histogram
+0.2100
Beta (1Y vs SPY)
-0.26
Free Cash Flow
$1.79M
Gross Rev
$91.98M
Gross Profit
$91.98M
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
$18.27M
Net Income
$14.60M
EPS (Diluted)
0.78
Price & Volume History
Loading chart…
Recent News
Amerisafe: Q3 Earnings Snapshot
Associated Press · Oct 28, 2026 5:06 PM ET
AMERISAFE Announces 2026 Third Quarter Results
Business Wire · Oct 28, 2026 4:05 PM ET
Globe Life (GL) Lags Q3 Earnings and Revenue Estimates
Zacks · Oct 21, 2026 4:50 PM ET
AMERISAFE Announces 2026 Third Quarter Earnings Release and Conference Call Schedule
Business Wire · Oct 1, 2026 4:05 PM ET
Here's Why Investors Should Stay Neutral on AMSF Stock for Now
Zacks · Sep 30, 2026 10:17 AM ET
AXT Inc. (AXTI) Climbs 16% on S&P 600 Addition
Insider Monkey · Sep 21, 2026 4:00 PM ET
GL Outperforms Industry, Trades at a Discount: How to Play the Stock
Zacks · Sep 18, 2026 10:43 AM ET
AM Best Affirms Credit Ratings of AMERISAFE, Inc. and Its Operating Subsidiaries
Business Wire · Sep 10, 2026 10:56 AM ET
Bloom Energy, Illumina, and Everpure Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600
PR Newswire · Sep 4, 2026 7:15 PM ET
Teladoc nabs insurance veteran as new CFO
Healthcare Dive · Aug 31, 2026 6:37 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See AMSF's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.